Brian F. Sullivan is the CEO and co-founder of Celcuity Inc., a company focused on pharmaceutical advancements. With an MBA from a top business school, he brings over 25 years of experience building successful technology companies. Before joining Celcuity in...
Brian F. Sullivan is the CEO and co-founder of Celcuity Inc., a company focused on pharmaceutical advancements. With an MBA from a top business school, he brings over 25 years of experience building successful technology companies. Before joining Celcuity in 2012, he was the Chairman and CEO of SterilMed, which sold for $330 million, and he also co-founded Recovery Engineering, which was acquired by Procter & Gamble for $265 million. During his time at Celcuity, he has overseen significant developments, transitioning the company into a leader in its field. Sullivan has pioneered compensation structures tied to company milestones, allowing for incentive payments that drive performance. Interestingly, his total compensation fluctuated from about $490,000 in 2017 to about $1.7 million in 2023, reflecting this alignment with company performance. Recently, he made significant insider trades, showcasing confidence in the company's future, with his holdings reaching peaks over $79 million. Sullivan's journey reflects a blend of experience in both startups and established businesses, highlighting his solid foundation in the industry.